Medtech Archives - Page 27 of 121 - Boston Life Sciences Times

Iterative Health Raises $77 Million to Expand Clinical Research Network

April 30, 2026

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

April 28, 2026

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

April 27, 2026

THIS WEEK'S STORIES

Motif Neurotech Wins FDA Clearance to Launch First Human Trial for Depression Implant

April 27, 2026

Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study

April 30, 2026

AstraZeneca’s SAPHNELO Approved in U.S. as Self-Injectable Treatment for Lupus

April 27, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Medtech

Axoft Raises $55 Million to Expand Brain-Computer Interface Trials and Manufacturing

Study Maps Microplastics Throughout the Body, Revealing Organ-Level Effects

Study Finds Masimo Pulse Oximetry Accurate Across Skin Tones in Newborns

Neurable Shifts to Licensing Model to Expand Brain-Computer Interface Technology

LightForce Launches Patient-Specific 3D-Printed Metal Braces

Most Read

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

FDA Advisory Panel Backs AstraZeneca’s TRUQAP Combination for PTEN-Deficient Prostate Cancer

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

Johnson & Johnson Names Ryan Koors Vice President of Investor Relations

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

Motif Neurotech Wins FDA Clearance to Launch First Human Trial for Depression Implant

Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study

AstraZeneca’s SAPHNELO Approved in U.S. as Self-Injectable Treatment for Lupus

POPULAR CATEGORY

ABOUT US

FOLLOW US